Paweł Daszkiewicz

Paweł Daszkiewicz

Auto-generated profile, based on publicly available information

Paweł Daszkiewicz

Childrens Mem Hlth Inst, Dept Neurosurg, Dzieci Polskich 20, PL-04730 Warsaw, Poland

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Epilepsy Research
Verified
Journal Article
Closed access
AKAnna Konopka
Anna Konopka
WGWiesława Grajkowska
Wiesława Grajkowska
KZKlaudia Ziemiańska
Klaudia Ziemiańska
MRMarcin Roszkowski
Marcin Roszkowski
PDPaweł Daszkiewicz
Paweł Daszkiewicz
JDJoanna Dzwonek
Joanna Dzwonek

1 April 2014 in Pediatric Neurology
Verified
Journal Article
Closed access
KKKatarzyna Kotulska-Jóźwiak
Katarzyna Kotulska-Jóźwiak
JBJulita Borkowska
Julita Borkowska
MRMarcin Roszkowski
Marcin Roszkowski
Marek ManderaMarek Mandera
Marek Mandera
PDPaweł Daszkiewicz
Paweł Daszkiewicz
Sergiusz JóźwiakSergiusz Jóźwiak
Sergiusz Jóźwiak

8 October 2010 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
AOAgnieszka Ondruch
Agnieszka Ondruch
AMAgnieszka Maryniak
Agnieszka Maryniak
TKTomasz Kropiwnicki
Tomasz Kropiwnicki
MRMarcin Roszkowski
Marcin Roszkowski
PDPaweł Daszkiewicz
Paweł Daszkiewicz

11 April 2015 in Journal of Neuro-Oncology
Verified
Journal Article
Open access
PDF file
MLMaria Lastowska
Maria Lastowska
EJElzbieta Jurkiewicz
Elzbieta Jurkiewicz
JTJoanna Trubicka
Joanna Trubicka
PDPaweł Daszkiewicz
Paweł Daszkiewicz
MDMonika Drogosiewicz
Monika Drogosiewicz
BDBozenna Dembowska-Baginska
Bozenna Dembowska-Baginska
Recent studies revealed the biological heterogeneity of medulloblastoma, with the existence of at least four groups which are associated with several clinical and morphological features. We investigated for further correlations between molecular types, location of tumours, their contrast enhancement pattern and survival of patients. Altogether 76 tumours were analyzed and molecular subtypes were identified by immunohistochemistry using representative antibodies, detection of chromosome 6 monosomy and CTNNB1 mutation. The site of the tumour was assessed on diagnosis using Magnetic Resonance images and intra-operative surgical reports. In addition, the gadolinium enhancement pattern was also investigated in pre-treatment tumours. Cerebellar hemispheric location was associated with SHH tumours (p < 0.001), as opposed to midline location being typical for WNT and non-WNT/SHH tumours. Remarkably, for patients with non-WNT/SHH tumours, the extensive gadolinium enhancement pattern (present in >75 % of tumour volume) predicted worse OS and EFS than for those with none/weak or heterogeneous enhancement (>10–75 % of tumour volume), (both p < 0.001). Our analysis indicates that distribution of the medulloblastoma tumours location is related to the biological characteristics of tumour. Importantly, the enhancement pattern of the tumour may be a clinically useful prognostic marker for patients with non-WNT/SHH medulloblastomas.

5 April 2012 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
DODorota Olczak-Kowalczyk
Dorota Olczak-Kowalczyk
MDMarta Daszkiewicz
Marta Daszkiewicz
KSKrasuska‐ Sławińska
Krasuska‐ Sławińska
BDBozenna Dembowska-Baginska
Bozenna Dembowska-Baginska
Dariusz GozdowskiDariusz Gozdowski
Dariusz Gozdowski
KSKatarzyna Semczuk
Katarzyna Semczuk

6 May 2009 in Child's Nervous System
Verified
Journal Article
Closed access
PDPaweł Daszkiewicz
Paweł Daszkiewicz
AMAgnieszka Maryniak
Agnieszka Maryniak
MRMarcin Roszkowski
Marcin Roszkowski
SBSławomir Barszcz
Sławomir Barszcz